Summit Securities Group’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-401
Closed -$2.07M 827
2021
Q1
$2.07M Sell
401
-71
-15% -$3.9K 0.23% 96
2020
Q4
$2.64M Sell
472
-94
-17% -$5.02K 0.22% 116
2020
Q3
$3.14M Sell
566
-94
-14% -$4.88K 0.33% 62
2020
Q2
$3M Buy
+660
New +$29.5K 0.37% 59

Other funds holding QGEN

Summit Securities Group's QGEN Position: Q2 2026 in Review

Summit Securities Group sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 5,000 shares — an estimated $200K sold.

Summit Securities Group first reported a position in QGEN in Q2 2020 and held it in 7 quarters. The position peaked at $7.48M in Q2 2023. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Summit Securities Group reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Summit Securities Group sold 5,000 Qiagen shares in Q2 2026, an estimated $200K.
  • Summit Securities Group first reported a position in Qiagen in Q2 2020 and held it in 7 quarters.
  • Summit Securities Group's Qiagen position peaked at $7.48M in Q2 2023.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.